BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17044299)

  • 41. Unresectable hepatocellular carcinoma: the need for an individualized multidisciplinary approach.
    Levy AE; Kowdley KV
    J Clin Gastroenterol; 2001 Sep; 33(3):180-2. PubMed ID: 11500603
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of hepatocellular carcinoma by percutaneous interventional methods.
    Livraghi T; Meloni F
    Hepatogastroenterology; 2002; 49(43):62-71. PubMed ID: 11941986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Technologies for ablation of hepatocellular carcinoma.
    Callstrom MR; Charboneau JW
    Gastroenterology; 2008 Jun; 134(7):1831-5. PubMed ID: 18486619
    [No Abstract]   [Full Text] [Related]  

  • 44. Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.
    Arrivé L; Rosmorduc O; Dahan H; Fartoux L; Monnier-Cholley L; Lewin M; Poupon R; Tubiana JM
    AJR Am J Roentgenol; 2003 Jan; 180(1):159-62. PubMed ID: 12490495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasonic guided percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas.
    Kai L; Jia L; Zhi-Gang W; Lei Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e102-4. PubMed ID: 26728664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical-shift MR imaging of acetic acid during percutaneous chemical ablation therapy: preliminary work.
    Roberts DA; Rosen MA; Clark TW; Mondschein J; Soulen MC; Siegelman E; Leigh JS
    J Vasc Interv Radiol; 2002 Oct; 13(10):1055-9. PubMed ID: 12397130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non-Surgical tumor ablation of hepatocellular carcinoma].
    Koike Y; Omata M
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1276-9. PubMed ID: 14518406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation of hepatocellular carcinoma.
    Livraghi T
    Surg Oncol Clin N Am; 2011 Apr; 20(2):281-99, viii. PubMed ID: 21377584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.
    Dewhirst MW; Landon CD; Hofmann CL; Stauffer PR
    Surg Oncol Clin N Am; 2013 Jul; 22(3):545-61. PubMed ID: 23622079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Interstitial percutaneous therapies in primary and secondary liver tumors].
    Torzilli G; Livraghi T; Olivari N
    Ann Ital Chir; 1999; 70(2):185-94. PubMed ID: 10434450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helical CT findings in patients with hepatocellular carcinoma treated with percutaneous ablation procedures.
    Catalano O; Cusati B; Sandomenico F; Nunziata A; Siani A
    J Comput Assist Tomogr; 2000; 24(5):748-54. PubMed ID: 11045698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver ablation therapy.
    Gillams AR
    Br J Radiol; 2004 Sep; 77(921):713-23. PubMed ID: 15447955
    [No Abstract]   [Full Text] [Related]  

  • 54. [Assessment of hepatocarcinoma treated with percutaneous ablation].
    Lencioni R; Paolicchi A; Armillotta N; Cioni D; Donati F; Bartolozzi C
    Radiol Med; 1998 May; 95(5 Suppl 1):53-8. PubMed ID: 9687904
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of percutaneous ethanol injection in the treatment of hepatocellular carcinoma.
    Livraghi T
    Dig Dis; 2001; 19(4):292-300. PubMed ID: 11935089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The principle of interventional therapy of hepatoma].
    Zhao JN
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):784. PubMed ID: 16248955
    [No Abstract]   [Full Text] [Related]  

  • 57. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Quality of life in the treatment of hepatocellular carcinoma].
    Shiina S; Teratani T; Omata M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():797-800. PubMed ID: 11762059
    [No Abstract]   [Full Text] [Related]  

  • 60. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.